查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866381

實驗室自動化市場－2025-2030年預測

Laboratory Automation Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

實驗室自動化市場預計將從 2025 年的 54.06 億美元成長到 2030 年的 76.71 億美元，複合年成長率為 7.25%。

實驗室自動化系統利用先進的儀器設備簡化實驗室流程，最大限度地減少人為干預，從而提高效率、準確性和安全性。這些系統最佳化了從單一步驟到整個工作流程的各項任務，減少了試劑用量，最大限度地減少了廢棄物，並提高了實驗通量。在人們對自動化優勢的認知不斷提高、技術進步以及藥物研發和生物技術領域投資不斷成長的推動下，全球實驗室自動化市場預計將穩步成長。然而，高昂的生產和實施成本，以及中小企業（SME）的緩慢採用，可能會阻礙市場擴張。

市場促進因素

硬體領域的優勢

硬體領域（包括實驗室機器人和自動化工作站）佔據了最大的市場佔有率。對加速研發和藥物開發日益成長的需求推動了對這些組件的需求，這些組件能夠提高生產效率並簡化複雜流程。特別是自動化工作站，由於其能夠高效處理高工作負載，有助於實驗室運作的擴充性，從而推動市場成長，並因此得到了廣泛應用。

臨床化學應用

臨床化學領域憑藉自動化技術在人員配備較少的情況下處理大量工作，佔據了市場主導地位。對具備結果管理、儲存和歸檔等自動化功能的專業實驗室的需求不斷成長，進一步推動了市場需求。臨床化學領域的自動化提高了準確性並縮短了前置作業時間，符合業界對營運效率和數據可靠性的追求。

市場限制

開發和實施自動化系統的高成本構成了一大障礙，尤其對於預算有限的中小型企業而言更是如此。此外，基礎設施和專業知識的匱乏也減緩了小型實驗室採用先進技術的步伐，限制了市場滲透率。應對這些挑戰需要經濟高效的解決方案和提高公眾意識，這將有助於技術的更廣泛應用。

市場區隔分析

根據交付方式，市場可分為硬體和軟體兩部分，其中硬體因其在自動化系統中的重要性而佔據主導地位。根據應用領域，臨床化學佔據最大佔有率，這主要得益於對高通量的需求；其次是藥物研發和基因組學。生技和製藥產業是最大的終端用戶，其需求主要來自管理產品複雜性、降低營運成本、透過自動化加速藥物研發。其他終端使用者包括學術研究機構和臨床診斷實驗室。

從地區來看，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療保健基礎設施、創新技術的廣泛應用以及主要企業的存在；而亞太地區預計將實現最快的成長，這得益於醫療保健投資的增加、研發領域的快速發展以及中國和印度等國家技術的日益普及。

競爭格局

羅氏等主要企業正透過人工智慧、機器學習和機器人等先進解決方案推動創新。這些企業正積極推行合作策略，包括產品發布和夥伴關係，以拓展市場影響。其重點在於為生物技術和製藥行業的終端用戶提供可擴展且高效的自動化系統，從而提高生產效率和數據準確性。

區域分析

北美地區的領先地位歸功於其強大的醫療保健生態系統和對自動化技術的早期應用，而亞太地區則憑藉不斷成長的醫療基礎設施投資和日益活躍的研發活動，成為成長熱點。南美洲新興市場也蘊藏著機遇，但成本限制減緩了科技的普及。

實驗室自動化市場預計將迎來強勁成長，這主要得益於硬體技術的進步、臨床化學應用以及生物技術/製藥產業的需求。北美市場主導，而亞太地區的快速發展也展現出巨大的潛力。儘管高成本和中小企業採用自動化技術的障礙仍然存在，但人工智慧和機器人技術的持續創新和策略性投資將有助於保持市場成長勢頭，並提高實驗室流程的效率和安全性。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

5. 按組件分類的實驗室自動化市場

  • 介紹
  • 硬體
  • 軟體
  • 服務

6. 按自動化類型分類的實驗室自動化市場

  • 介紹
  • 模組化的
  • 全自動型

第7章：按應用分類的實驗室自動化市場

  • 介紹
  • 免疫診斷
  • 分子診斷
  • 藥物研發
  • 血液分析
  • 其他

第8章：按最終用戶分類的實驗室自動化市場

  • 介紹
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究和學術機構

9. 按地區分類的實驗室自動化市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第11章：公司簡介

  • Danaher Corporation
  • Abbott Laboratories
  • PerkinElmer, Inc.
  • Tecan Trading AG
  • Synchron
  • Hudson Robotics Inc.
  • F. Hoffmann-La Roche AG
  • Scienion AG
  • Thermo Fisher Scientific
  • COPAN ITALIA spa
  • Horiba, Ltd.
  • Oracle Corporation
  • HighRes Biosolutions

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061612280

The Laboratory Automation Market will rise from USD 5.406 billion in 2025 to USD 7.671 billion in 2030, with a 7.25% compound annual growth rate (CAGR).

Laboratory automation systems employ advanced instrumentation to streamline laboratory processes with minimal human intervention, enhancing efficiency, accuracy, and safety. These systems optimize tasks from single steps to entire workflows, reducing reagent use, minimizing waste, and increasing experimental throughput. The global laboratory automation market is poised for steady growth, driven by growing awareness of automation benefits, technological advancements, and rising investments in drug discovery and biotechnology. However, high production and deployment costs, along with slower adoption among small and medium-sized enterprises (SMEs), may impede market expansion.

Market Drivers

Hardware Segment Dominance

The hardware segment, encompassing laboratory robotics and automated workstations, holds the largest market share. The increasing need for accelerated research and pharmaceutical development fuels demand for these components, as they enhance productivity and streamline complex processes. Automated workstations, in particular, are adopted for their ability to handle high workloads efficiently, supporting scalability in laboratory operations and driving market growth.

Clinical Chemistry Applications

The clinical chemistry segment dominates due to its reliance on automation to manage high workloads with reduced manpower. The growing need for specialized laboratories with automated functions, such as result management, storage, and archiving, further boosts demand. Automation in clinical chemistry enhances precision and reduces lead times, aligning with the industry's push for operational efficiency and data reliability.

Market Restraints

High costs associated with developing and deploying automation systems pose a significant barrier, particularly for SMEs with limited budgets. Additionally, the slower adoption of advanced technologies in smaller labs, due to insufficient infrastructure or expertise, limits market penetration. These challenges necessitate cost-effective solutions and increased awareness to broaden adoption.

Market Segment Analysis

By offering, the market is divided into hardware and software, with hardware leading due to its critical role in automation systems. By application, clinical chemistry holds a dominant share, driven by high-throughput needs, followed by drug discovery and genomics. The biotechnology and pharmaceutical companies segment is the largest end-user, propelled by the need to manage product complexity, reduce operational costs, and accelerate drug development through automation. Other end-users include academic research and clinical diagnostics.

Geographically, North America commands the largest market share, supported by advanced healthcare infrastructure, widespread adoption of innovative technologies, and the presence of major players. The Asia-Pacific region is expected to experience the fastest growth, driven by increasing healthcare investments, rapid R&D sector development, and growing technology adoption in countries like China and India.

Competitive Landscape

Key players, such as F. Hoffmann-La Roche AG, are driving innovation through advanced solutions like AI, machine learning, and robotics. These companies pursue collaborative strategies, including product launches and partnerships, to expand their market presence across diverse applications. The focus is on delivering scalable, efficient automation systems that enhance productivity and data accuracy for end-users in biotechnology and pharmaceuticals.

Regional Analysis

North America's dominance stems from its robust healthcare ecosystem and early adoption of automation technologies. The Asia-Pacific region, however, is a hotspot for growth, fueled by rising healthcare infrastructure investments and expanding R&D activities. Emerging markets in South America also present opportunities, though adoption lags due to cost constraints.

The laboratory automation market is set for robust growth, driven by hardware advancements, clinical chemistry applications, and biotechnology/pharmaceutical demands. North America leads, while Asia-Pacific's rapid development signals strong potential. High costs and SME adoption barriers pose challenges, but ongoing innovations in AI and robotics, coupled with strategic investments, will sustain market momentum, enhancing efficiency and safety in laboratory processes.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Laboratory Automation Market is analyzed into the following segments:

By Component

  • Hardware
  • Software
  • Services

By Automation Type

  • Modular
  • Fully-Automated

By Application

  • Immunodiagnostics
  • Molecular Diagnostics
  • Drug Development
  • Hematology
  • Others

By End-User

  • Hospitals & Diagnostics Centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LABORATORY AUTOMATION MARKET BY COMPONENT

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software
  • 5.4. Services

6. LABORATORY AUTOMATION MARKET BY AUTOMATION TYPE

  • 6.1. Introduction
  • 6.2. Modular
  • 6.3. Fully-Automated

7. LABORATORY AUTOMATION MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Immunodiagnostics
  • 7.3. Molecular Diagnostics
  • 7.4. Drug Development
  • 7.5. Hematology
  • 7.6. Others

8. LABORATORY AUTOMATION MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Diagnostics Centers
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. LABORATORY AUTOMATION MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Danaher Corporation
  • 11.2. Abbott Laboratories
  • 11.3. PerkinElmer, Inc.
  • 11.4. Tecan Trading AG
  • 11.5. Synchron
  • 11.6. Hudson Robotics Inc.
  • 11.7. F. Hoffmann- La Roche AG
  • 11.8. Scienion AG
  • 11.9. Thermo Fisher Scientific
  • 11.10. COPAN ITALIA spa
  • 11.11. Horiba, Ltd.
  • 11.12. Oracle Corporation
  • 11.13. HighRes Biosolutions

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations